MiRNA-Based Therapies for Lung Cancer: Opportunities and Challenges?

Lung cancer is a commonly diagnosed cancer and the leading cause of cancer-related deaths, posing a serious health risk. Despite new advances in immune checkpoint and targeted therapies in recent years, the prognosis for lung cancer patients, especially those in advanced stages, remains poor. MicroR...

Full description

Bibliographic Details

Published in:	Biomolecules
Main Authors:	Han Yang, Yufang Liu, Longqing Chen, Juanjuan Zhao, Mengmeng Guo, Xu Zhao, Zhenke Wen, Zhixu He, Chao Chen, Lin Xu
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Subjects:	microRNAs lung cancer chemoradiotherapy targeted therapy immunotherapy MiRNA-based therapy
Online Access:	https://www.mdpi.com/2218-273X/13/6/877